Insider Ledger
AIM ImmunoTech Inc. (AIM) insider buying and SEC filings
AIM ImmunoTech Inc. · CIK 946644
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- NYSE
- Industry (SIC)
- Biological Products, (No Diagnostic Substances)
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- AIM ImmunoTech Inc.; HEMISPHERX BIOPHARMA INC
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 23, 2026 | Purchase (code P) | Thomas K Equels (CEO and Director) bought 31,675 shares at $0.1600 ($5K), reported as a purchase (code P). Holdings up 20% to 189,747 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 26, 2026, 12:12 PM ET |
| Oct 22, 2026 | Purchase (code P) | Thomas K Equels (CEO and Director) bought 31,250 shares at $0.1630 ($5K), reported as a purchase (code P). Holdings up 25% to 158,072 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 23, 2026, 12:29 PM ET |
| Sep 17, 2026 | Purchase (code P) | Thomas K Equels (CEO and Director) bought 24,000 shares at $0.2100 ($5K), reported as a purchase (code P). Holdings up 23% to 126,822 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 18, 2026 |
| Sep 16, 2026 | Purchase (code P) | Thomas K Equels (CEO and Director) bought 11,000 shares at $0.2100 ($2K), reported as a purchase (code P). Holdings up 12% to 102,822 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 17, 2026 |
| Sep 15, 2026 | Purchase (code P) | Thomas K Equels (CEO and Director) bought 22,000 shares at $0.2200 ($5K), reported as a purchase (code P). Holdings up 32% to 91,822 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 16, 2026 |
| Sep 14, 2026 | Purchase (code P) | Thomas K Equels (CEO and Director) bought 5,900 shares at $0.2200 ($1K), reported as a purchase (code P). Holdings up 9% to 69,822 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 15, 2026 |
5 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow AIM in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.